Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Cachexia
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Inflammatory === Certain molecules in the body, called [[Inflammatory cytokine]]s, play a big role in causing cachexia. Two important ones are [[tumor necrosis factor|tumor necrosis factor (TNF)]] and [[interleukin 6|interleukin 6 (IL-6)]].<ref name="fearon-2012" /> ==== Tumor Necrosis Factor (TNF) ==== TNF breaks down muscle and fat while stopping new muscle and fat cells from forming by activating the [[ubiquitin proteasome pathway]].<ref name="ferrer-2023" /><ref name="fearon-2012" /><ref name="Kumar" /><ref name="petruzzelli-2016">{{Cite journal |last1=Petruzzelli |first1=Michele |last2=Wagner |first2=Erwin F. |date=2016-03-01 |title=Mechanisms of metabolic dysfunction in cancer-associated cachexia |journal=Genes & Development |language=en |volume=30 |issue=5 |pages=489–501 |doi=10.1101/gad.276733.115 |issn=0890-9369 |pmc=4782044 |pmid=26944676}}</ref><ref name="nishikawa-2021" /><ref name="setiawan-2023">{{Cite journal |last1=Setiawan |first1=Tania |last2=Sari |first2=Ita Novita |last3=Wijaya |first3=Yoseph Toni |last4=Julianto |first4=Nadya Marcelina |last5=Muhammad |first5=Jabir Aliyu |last6=Lee |first6=Hyeok |last7=Chae |first7=Ji Heon |last8=Kwon |first8=Hyog Young |date=2023-05-22 |title=Cancer cachexia: molecular mechanisms and treatment strategies |journal=Journal of Hematology & Oncology |language=en |volume=16 |issue=1 |page=54 |doi=10.1186/s13045-023-01454-0 |doi-access=free |issn=1756-8722 |pmc=10204324 |pmid=37217930}}</ref> It also triggers the release of other cytokines that also speed up muscle loss. Since this process is very complex, cachexia is unlikely to be caused by one molecule.<ref name="petruzzelli-2016" /> While it is thought to be produced by immune cells called [[macrophage]]s, scientists are still unsure of exactly where TNF is produced in cachexia.<ref name="fearon-2012" /> ==== Interleukin-6 (IL-6) ==== IL-6 is thought to cause muscle loss by starting a pathway called the [[JAK-STAT signaling pathway|JAK/STAT pathway]].<ref name="ferrer-2023" /><ref name="fearon-2012" /><ref name="setiawan-2023" /><ref>{{Cite journal |last1=Moresi |first1=Viviana |last2=Adamo |first2=Sergio |last3=Berghella |first3=Libera |date=2019-04-30 |title=The JAK/STAT Pathway in Skeletal Muscle Pathophysiology |journal=Frontiers in Physiology |volume=10 |page=500 |doi=10.3389/fphys.2019.00500 |doi-access=free |issn=1664-042X |pmc=6502894 |pmid=31114509}}</ref> IL-6 is produced by immune cells called macrophages, potentially producing [[acute phase reactants]] which may worsen muscle loss.<ref name="fearon-2012" /><ref name="petruzzelli-2016" /> Other molecules may include: * [[Myostatin]] - Prevents muscle growth and is often higher in people with cancer.<ref name="fearon-2012" /><ref name="petruzzelli-2016" /><ref name="argiles-2016">{{cite journal |vauthors=Argilés JM, Campos N, Lopez-Pedrosa JM, Rueda R, Rodriguez-Mañas L |date=September 2016 |title=Skeletal Muscle Regulates Metabolism via Interorgan Crosstalk: Roles in Health and Disease |journal=Journal of the American Medical Directors Association |volume=17 |issue=9 |pages=789–96 |doi=10.1016/j.jamda.2016.04.019 |pmid=27324808 |doi-access=free}}</ref> * Activin - May contribute to muscle loss when TNF is also active.<ref name="fearon-2012" /><ref name="petruzzelli-2016" /> * Growth Differentiation Factor 15 (GDF-15) - Normally produced during cellular stress. Thought to play a role in food aversion and is associated with reduced food intake.<ref name="ferrer-2023" />
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)